Yu, Zhi
Kim, Seoyoung C.
Vanni, Kathleen
Huang, Jie
Desai, Rishi
Murphy, Shawn N.
Solomon, Daniel H.
Liao, Katherine P.
Funding for this research was provided by:
National Institutes of Health (R01 EB014947, U54 LM008748)
National Institutes of Health (U01 HG008685)
National Institutes of Health (U54 HG007963)
National Institutes of Health (R01 HL127118)
Patient-Centered Outcomes Research Institute (PCORI 282364.5077585.0007)
Harold and Duval Bowen Fund
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30 AR2072577)
Article History
Received: 2 December 2017
Accepted: 18 April 2018
First Online: 1 June 2018
Change Date: 8 July 2019
Change Type: Correction
Change Details: Following publication of the original article [1], it has come to our attention that we did not appropriately convert the units for CRP from the National Health and Nutrition Examination Survey (NHANES) from mg/dL to mg/L. In this study, NHANES was considered the general population cohort for this study; interestingly, the correction resulted in changes to a broader range of CRP values in NHANES from 0.01 to 18.0 mg/dL to 0.10 to 180.0 mg/L.
Ethics approval and consent to participate
: Our study protocol was approved by the Partners Healthcare Institutional Review Board.
: All authors have completed the Unified Competing Interest form and declare the following interests: SCK receives research grants to Brigham and Women’s Hospital from Pfizer, Lilly, Genentech, AstraZeneca, and Bristol-Myers Squibb. DHS receives research grants to Brigham and Women’s Hospital from Amgen, Lilly, Pfizer, AstraZeneca, Bristol-Myers Squibb, Genentech, and Corrona. He serves in an unpaid capacity on a Pfizer-sponsored trial on an unrelated topic. He receives royalties from UpToDate on unrelated topics. No other authors report any disclosures.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.